Scott Brun

Scott Brun is the President of Gold Mast Consulting, LLC, an advisory firm he founded to provide strategic guidance and technical advice in the biopharmaceutical sector. His expertise encompasses areas such as research and development, pipeline portfolio management, commercialization of new therapeutics, and strategic communications related to R&D activities.14

Professional Background

• Education: Dr. Brun earned his B.S. in Biochemistry from the University of Illinois at Urbana-Champaign and his M.D. from Johns Hopkins University School of Medicine. He completed his residency in ophthalmology at the Massachusetts Eye and Ear Infirmary, affiliated with Harvard Medical School.1
• Experience at AbbVie: Prior to founding Gold Mast Consulting, Dr. Brun spent over 20 years at AbbVie and its predecessor company, Abbott Laboratories. His roles included Vice President of Scientific Affairs and Head of AbbVie Ventures, where he focused on investment opportunities within AbbVie’s R&D therapeutic areas.15
• Current Roles: In addition to his position at Gold Mast Consulting, Dr. Brun serves as a Senior Advisor to Horizon Therapeutics plc, a Venture Partner at Abingworth LLP, and a Senior Medical Advisor at Launch Therapeutics. He is also involved with several biopharmaceutical companies as a board member.12

Key Contributions

Dr. Brun's work is characterized by his extensive experience in drug development and business strategy within the pharmaceutical industry, making him a significant figure in the field of biopharmaceutical consulting.36